Literature DB >> 9709958

Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male.

W Byrd1, M J Bennett, B R Carr, Y Dong, F Wians, W Rainey.   

Abstract

Inhibins are glycoprotein members of the transforming growth factor-beta family that have been implicated in the control of spermatogenesis by exerting a negative feedback on FSH secretion. In addition, locally produced inhibins may play a role in paracrine regulation of testicular function. Immunoassays were used to measure the two biologically active dimeric forms of inhibin (inhibin A and B) in serum, seminal plasma, and urine. To better define their actions, inhibins were measured in the male during infancy, sexual maturation, and senescence. Inhibin B but not A was measurable in the serum of male newborns, infants, children, and adults. In adult males, measurable levels of inhibin B were detected in the seminal plasma but not the urine. The circulating levels of inhibin B increased shortly after birth and peaked at 4-12 months of age (210 +/- 31 pg/mL). The concentration measured in the serum then decreased to a low of 81 +/- 12 pg/mL of inhibin B from 3-9 yr of age followed by a gradual increase beginning with the onset of puberty and reaching another peak of 167 +/- 20 pg/mL in males who were 20-30 yr of age. Inhibin B levels then gradually declined with increasing age up through 90 yr of age. Serum levels of gonadotropins and total testosterone production were also measured in these same males. There was a brief increase in the gonadotropins (FSH and LH) during the few months of postnatal development, followed by a decrease to basal levels until the onset of puberty at 10-14 yr of age. Testosterone was also increased in the serum of infants from day 1 through 12 months of age, which decreased in young children but increased again following the elevation of gonadotropins during puberty. In adults aged 20-90 yr, serum levels of inhibin B were inversely proportional to levels of FSH but not LH or testosterone. In males in which a semen analysis was performed, those males with normal semen analysis had a significantly higher inhibin B levels, sperm production, and lower FSH levels than males with either oligospermia or nonobstructive azoospermia. The levels of Inhibin B found in circulation were a good marker for testicular function and could be useful in the diagnosis of patients with semen abnormalities or a complete absence of spermatogenesis. Because this glycoprotein is secreted in high amounts in the prepubertal testis up to 3 yr of age, inhibin B could potentially be used as a marker in the diagnosis of cryptorchidism and precocious puberty.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709958     DOI: 10.1210/jcem.83.8.5008

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys.

Authors:  D Cortes; J Thorup; E Hogdall; B Norgaard-Pedersen; B L Petersen; C Hogdall
Journal:  Pediatr Surg Int       Date:  2006-12-14       Impact factor: 1.827

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  SOT Symposium Highlight: Translatable Indicators of Testicular Toxicity: Inhibin B, MicroRNAs, and Sperm Signatures.

Authors:  Edward Dere; Linnea M Anderson; Michelle Coulson; Barry S McIntyre; Kim Boekelheide; Robert E Chapin
Journal:  Toxicol Sci       Date:  2013-09-19       Impact factor: 4.849

4.  The role of varicocele sclerotherapy in men with severe oligo-astheno-teratozoospermia.

Authors:  Mazen A Ghanem; Manal A Safan; Ashraf A Ghanem; Gert R Dohle
Journal:  Asian J Androl       Date:  2011-07-25       Impact factor: 3.285

5.  Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function.

Authors:  Paul A Boepple; Frances J Hayes; Andrew A Dwyer; Taneli Raivio; Hang Lee; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

Review 6.  Biomarkers for assessing reproductive development and health: Part 1--Pubertal development.

Authors:  John C Rockett; Courtney D Lynch; Germaine M Buck
Journal:  Environ Health Perspect       Date:  2004-01       Impact factor: 9.031

7.  A Normative Model of Serum Inhibin B in Young Males.

Authors:  Thomas W Kelsey; Amy Miles; Rod T Mitchell; Richard A Anderson; W Hamish B Wallace
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

8.  Curative GnRHa treatment has an unexpected repressive effect on Sertoli cell specific genes.

Authors:  Katharina Gegenschatz-Schmid; Gilvydas Verkauskas; Philippe Demougin; Vytautas Bilius; Darius Dasevicius; Michael B Stadler; Faruk Hadziselimovic
Journal:  Basic Clin Androl       Date:  2018-02-09

Review 9.  Reactive oxygen species and male reproductive hormones.

Authors:  Mahsa Darbandi; Sara Darbandi; Ashok Agarwal; Pallav Sengupta; Damayanthi Durairajanayagam; Ralf Henkel; Mohammad Reza Sadeghi
Journal:  Reprod Biol Endocrinol       Date:  2018-09-11       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.